Silk Road Medical, Inc. revenue for the last year amounted to 177.13 M USD, the most of which — 177.13 M USD — came from its highest performing source at the moment, Transcarotid Artery Revascularization, the year earlier bringing 138.64 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Silk Road Medical, Inc. 177.13 M USD, and the year before that — 138.64 M USD.